文献速递神经MR

MRI引导聚焦超声开放血脑屏障在早期阿尔茨海默病患者中诱发脑膜静脉通透性

Blood-Brain Barrier Opening with MRI-guided Focused Ultrasound Elicits Meningeal Venous Permeability in Humans with Early Alzheimer Disease.
PubMed 文献 · Radiology · 2021-01-05

该前瞻性II期临床试验纳入3例早期阿尔茨海默病女性患者,采用220-kHz聚焦超声联合微泡造影剂每2周一次开放海马和嗅内皮质血脑屏障,3.0-T MRI显示靶区即刻精准强化、24小时内消退,随后出现一过性静脉周围强化并持续24-48小时,无颅内出血等不良事件。

要点

  • 聚焦超声开放血脑屏障后靶区即刻出现空间精准的对比强化,24小时内消退确认屏障关闭。
  • 屏障关闭后静脉周围区域再次出现强化,持续24-48小时自行消退,提示血流-脑膜屏障通透性。
  • 3例患者均未出现颅内出血或其他不良事件。

核心结论

  • MRI引导聚焦超声可安全开放3例阿尔茨海默病患者海马区血脑屏障,治疗后MRI显示独特的时空对比强化模式,提示靶区下游静脉周围免疫愈合反应。

研究设计与样本

  • 健康保险流通与责任法案合规的前瞻性、进行中II期临床试验(NCT03671889),连续纳入3例早期阿尔茨海默病女性患者(年龄61、72、73岁),采用220-kHz换能器联合静脉微泡造影剂,每2周一次对海马和嗅内皮质进行三次聚焦超声开放血脑屏障操作,于2018年10月至2019年5月期间进行,治疗后用3.0-T MRI评估钆对比剂强化模式。

关键影像表现/征象

  • 治疗后靶区脑实质内可见明确对比强化,提示即刻空间精准的血脑屏障开放。
  • 所有治疗结束后24小时内脑实质强化消退,确认血脑屏障关闭。
  • 血脑屏障开放后急性期一致观察到一过性静脉周围强化。
  • 血脑屏障关闭后静脉周围区域再次出现对比强化,持续24-48小时后自行消退。
  • 未见颅内出血或其他不良事件证据。

临床应用与阅片要点

  • 作者认为治疗后MRI显示的独特时空对比强化模式提示靶区下游静脉周围免疫愈合反应。

局限性

  • 原文指出该操作在人阿尔茨海默病中的生理效应需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Opening of the blood-brain barrier (BBB) induced with MRI-guided focused ultrasound has been shown in experimental animal models to reduce amyloid-β plaque burden, improve memory performance, and facilitate delivery of therapeutic agents to the brain. However, physiologic effects of this procedure in humans with Alzheimer disease (AD) require further investigation. Purpose To assess imaging effects of focused ultrasound-induced BBB opening in the hippocampus of human participants with early AD and to evaluate fluid flow patterns after BBB opening by using serial contrast-enhanced MRI. Materials and Methods Study participants with early AD recruited to a Health Insurance Portability and Accountability Act-compliant, prospective, ongoing phase II clinical trial (ClinicalTrials.gov identifier, NCT03671889) underwent three separate focused ultrasound-induced BBB opening procedures that used a 220-kHz transducer with a concomitant intravenous microbubble contrast agent administered at 2-week intervals targeting the hippocampus and entorhinal cortex between October 2018 and May 2019. Posttreatment effects and gadolinium-based contrast agent enhancement patterns were evaluated by using 3.0-T MRI. Results Three women (aged 61, 72, and 73 years) consecutively enrolled in the trial successfully completed repeated focused ultrasound-induced BBB opening of the hippocampus and entorhinal cortex. Postprocedure contrast enhancement was clearly identified within the targeted brain volumes, indicating immediate spatially precise BBB opening. Parenchymal enhancement resolved within 24 hours after all treatments, confirming BBB closure. Transient perivenous enhancement was consistently observed during the acute phase after BBB opening. Notably, contrast enhancement reappeared in the perivenular regions after BBB closure. This imaging marker is consistent with blood-meningeal barrier permeability and persisted for 24-48 hours before spontaneous resolution. No evidence of intracranial hemorrhage or other adverse effect was identified. Conclusion MRI-guided focused ultrasound-induced blood-brain barrier opening was safely performed in the hippocampi of three participants with Alzheimer disease without any adverse effects. Posttreatment MRI reveals a unique spatiotemporal contrast enhancement pattern that suggests a perivenular immunologic healing response downstream from targeted sites. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Klibanov in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Mehta RI, Carpenter JS, Mehta RI, et al. Blood-Brain Barrier Opening with MRI-guided Focused Ultrasound Elicits Meningeal Venous Permeability in Humans with Early Alzheimer Disease. Radiology. 2021. PMID: 33399511. doi:10.1148/radiol.2021200643

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。